InvestorsHub Logo
Followers 1322
Posts 247510
Boards Moderated 56
Alias Born 12/07/2009

Re: None

Monday, 05/16/2022 9:02:47 AM

Monday, May 16, 2022 9:02:47 AM

Post# of 37566
$IXHL Incannex now targets a pre-IND meeting with the U.S. FDA in Q3 2022 to discuss an expedited clinical trial program.

https://finance.yahoo.com/news/incannex-announces-ihl-216a-observed-115500153.html


ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.